| Line item | 2025-03-31 FY | 2024-03-31 FY | 2023-03-31 FY | 2022-03-31 FY | 2022-02-22 FY | 2021-03-31 FY |
|---|---|---|---|---|---|---|
| Revenue | $144.00K | $109.00K | $370.00K | $1.50M | $1.50M | $0.00 |
| Cost of Revenue | $5.00K | – | – | – | – | $0.00 |
| Gross Profit | – | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – | – |
| R&D | $5.03M | $5.50M | $8.88M | $3.32M | – | $1.10M |
| SG&A | $7.73M | $9.70M | $9.22M | $9.66M | – | $15.72M |
| Operating Income | -$12.62M | -$15.09M | -$17.73M | -$11.48M | – | -$16.83M |
| Interest Expense | – | – | – | – | – | – |
| Tax Expense | $2.00K | $2.00K | $2.00K | $2.00K | – | $2.00K |
| Net Income | -$2.49M | -$14.67M | -$17.26M | -$11.45M | – | -$16.83M |
| EPS (basic) | -1.7000 | -1.6000 | -1.9800 | -1.3200 | – | – |
| EPS (diluted) | -1.7000 | -1.6000 | -1.9800 | -1.3200 | – | – |
| Shares (diluted) | $1.46M | $9.14M | $8.71M | $8.70M | – | – |